Clinical Trial Update: A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluating the safety and efficacy of DE-117 ophthalmic solution in patients with glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• DE-117 Ophthalmic Solution (DE-117)

Snippet

Sponsor: Santen Inc. | Conditions: Glaucoma and Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED